Manufacturer record
Square Pharmaceuticals: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
1 batch manufactured by Square Pharmaceuticals (West Bengal) was declared Not of Standard Quality in January 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: 51, Ofloxacin And Ornidazole Tablets IP (exp Oct 2026). West Bengal (state lab) found it not of standard quality: The sample declared as Misbranded Drug as per Sec 17(a) and 17(b) of Drugs and Cosmetics Act 1940 as it is not labelled in the prescribed. Listed in the January 2026 alert.
Records by type
1 record linked to Square Pharmaceuticals in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Ofloxacin And Ornidazole Tablets IP | Batch 51Mfg Nov 2024 · Exp Oct 2026 | The sample declared as Misbranded Drug as per Sec 17(a) and 17(b) of Drugs and Cosmetics Act 1940 as it is not labelled in the prescribed manner. The sample declared as Not of Standard Quality in respect of the Test Assay performed.Assay | West BengalState lab | Jan 2026 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.